CoChat

αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB

Monferran, Sylvie, Skuli, Nicolas, Delmas, Caroline, Favre, Gilles, Bonnet, Jacques, Cohen‐Jonathan‐Moyal, Elizabeth, Toulas, Christine · 2008 · International Journal of Cancer
Cited by 139

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Integrins are extracellular matrix receptors involved in tumour invasion and angiogenesis. Although there is evidence that inhibiting integrins might enhance the efficiency of radiotherapy, little is known about the exact mechanisms involved in the integrin‐dependent modulation of tumor radiosensitivity. The purpose of this study was to investigate the role of αvβ3 and αvβ5 integrins in glioblastoma cell radioresistance and overall to decipher the downstream biological pathways. We first demonstrated that silencing αvβ3 and αvβ5 integrins with specific siRNAs significantly reduced the survival after irradiation of 2 glioblastoma cell lines: U87 and SF763. We then showed that integrin activity and integrin signalling pathways controlled the glioma cell radiosensitivity. This regulation of glioma cell response to ionising radiation was mediated through the integrin‐linked kinase, ILK, and the small GTPase, RhoB, by two mechanisms. The first one, independent of ILK, consists in the regulation of the intracellular level of RhoB by αvβ3 or αvβ5 integrin. The second pathway involved in cell radiosensitivity consists in RhoB activation by ionising radiation through ILK. Furthermore, we demonstrated that the αvβ3/αvβ5 integrins/ILK/RhoB pathway controlled the glioma cells radiosensitivity by regulating radiation‐induced mitotic cell death. This work identifies a new biological pathway controlling glioblastoma cells radioresistance, activated from the membrane through αvβ3 and/or αvβ5 integrins via ILK and RhoB. Our results are clues that downstream effectors of αvβ3 and αvβ5 integrins as ILK and RhoB might also be promising candidate targets for improving the efficiency of radiotherapy and thus the clinical outcome of patients with glioblastoma. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ijc.23498

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 139

Metadata

Authors
Monferran, S., Skuli, N., Delmas, C., Favre, G., Bonnet, J., Cohen‐Jonathan‐Moyal, E., & Toulas, C.
Venue
International Journal of Cancer
Publisher
Wiley
Published
2008-05-07
Volume
123
Issue
2
Pages
357-364
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W2044136921
Cited by
139
References
1
FWCI
6.27
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB. https://app.cochat.ai/papers/10.1002/ijc.23498
The paper
Monferran, S., Skuli, N., Delmas, C., Favre, G., Bonnet, J., Cohen‐Jonathan‐Moyal, E., & Toulas, C. (2008). αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB. International Journal of Cancer. https://doi.org/10.1002/ijc.23498

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.